Analysts' Actions: P CI HUM LPX RDC
NEW YORK (
) --
CHANGE IN RATINGS
Cigna
(CI) - Get Report
upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $56 price target. New analyst also placed the company on the US Focus List. Company can continue to grow the business and return capital to shareholders. $56 price target.
Cepheid
(CPHD)
rated new Hold at Cantor. Valuation call, based on a $40 price target.
Equifax
(EFX) - Get Report
rated new Hold at Deutsche Bank. Valuation call, based on a $47 price target.
Humana
(HUM) - Get Report
downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $74 price target. New analyst has a $74 price target.
Louisiana-Pacific
(LPX) - Get Report
upgraded at BofA/Merrill from Underperform to Buy, Bank of America/Merrill Lynch said. Valuation call, based on a $16 price target.
Louisiana-Pacific downgraded at Deutsche. LPX was downgraded from Buy to Hold, Deutsche Bank said. Valuation call, based on a $12 price target.
Pandora
(P)
upgraded at Canaccord from Hold to Buy, Canaccord Genuity said. Visibility is improving. $16 price target.
Rowan
(RDC)
rated new Outperform at Credit Suisse. RDC was initiated with an Outperform rating, Credit Suisse said. $50 price target. Company was also placed on the Focus List. Company trades at a discount to its peers.
Vertex Pharmaceuticals
(VRTX) - Get Report
rated new Buy at ThinkEquity. $64 price target. Kalydeco should drive near-term growth.
STOCK COMMENTS / EPS CHANGES
Brown Forman
(BF.B)
numbers raised at UBS. Shares of BF.b now seen reaching $72, UBS said. Estimates also increased on positive outlook. Buy rating.
HJ Heinz
(HNZ)
numbers reduced at Credit Suisse. HNZ estimates were cut through 2015, Credit Suisse said. Company is seeing lower operating earnings. Neutral rating and new $57 price target.
Joy Global
(JOY)
numbers lowered at Jefferies. Shares of JOY now seen reaching $50, Jefferies said. Estimates also lowered on poor revenue outlook. Hold rating.
Pandora
(P)
estimates, target raised at Credit Suisse.Shares of P now seen reaching $13, according to Credit Suisse. Estimates also increased, as the company is realizing higher operating leverage. Neutral rating.
UnitedHealth
(UNH) - Get Report
cut from US Focus List at Credit Suisse. New analyst has a $62 price target. Outperform rating.
>To submit a news tip, email:
.
READERS ALSO LIKE:
>>Apple Ecosystem Offers New Hope
Follow
TheStreet
on
and become a fan on
This article was written by a staff member of TheStreet.
